# Structure Therapeutics Inc.: filings

GPCR · Nasdaq · CIK 1888886 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gpcr.md) · [Financials](/companies/gpcr/financials.md) · [Filings](/companies/gpcr/filings.md) · [Insiders](/companies/gpcr/insiders.md)

## Reports and events: 60 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 88, 8-K 36, 3 22, SCHEDULE 13G/A 17, 10-Q 11, SC 13G/A 10, CORRESP 9, SC 13G 9, UPLOAD 8, 4/A 5, 10-K 4, 144 4, D 4, EFFECT 4, S-8 4, 424B5 3, ARS 3, DEF 14A 3, S-1 3, SCHEDULE 13G 3, 10-Q/A 2, 424B4 2, DRS 2, DRS/A 2, DRSLTR 2, S-1MEF 2, SEC STAFF LETTER 2, 8-A12B 1, CERT 1, F-6 1, NT 10-Q 1, S-1/A 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-08 | 08:09 ET | [8-K](/filings/0001104659-26-105688.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-105688 |
| 2026-08-06 | 16:29 ET | [10-Q](/filings/0001104659-26-092057.md) | Quarterly report, period 2026-06-30 | 0001104659-26-092057 |
| 2026-08-06 | 16:13 ET | [8-K](/filings/0001104659-26-092017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-092017 |
| 2026-06-18 | 16:05 ET | [8-K](/filings/0001104659-26-075720.md) | 5.07 Shareholder vote results | 0001104659-26-075720 |
| 2026-05-07 | 16:45 ET | [10-Q](/filings/0001104659-26-057230.md) | Quarterly report, period 2026-03-31 | 0001104659-26-057230 |
| 2026-05-07 | 16:42 ET | [8-K](/filings/0001104659-26-057226.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-057226 |
| 2026-04-23 | 16:30 ET | [DEF 14A](/filings/0001104659-26-047740.md) | Proxy statement, period 2026-06-17 | 0001104659-26-047740 |
| 2026-04-15 | 06:05 ET | [8-K](/filings/0001104659-26-043425.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-043425 |
| 2026-03-16 | 08:01 ET | [8-K](/filings/0001104659-26-028023.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-028023 |
| 2026-02-26 | 16:40 ET | [10-K](/filings/0001104659-26-020562.md) | Annual report, period 2025-12-31 | 0001104659-26-020562 |
| 2026-02-26 | 16:11 ET | [8-K](/filings/0001104659-26-020494.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-020494 |
| 2026-01-05 | 16:07 ET | [8-K](/filings/0001104659-26-000620.md) | 1.01 Entry into a material agreement | 0001104659-26-000620 |
| 2025-12-10 | 17:06 ET | [8-K](/filings/0001104659-25-120015.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-120015 |
| 2025-12-08 | 08:47 ET | [8-K](/filings/0001104659-25-119095.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-119095 |
| 2025-11-06 | 16:59 ET | [10-Q](/filings/0001104659-25-107829.md) | Quarterly report, period 2025-09-30 | 0001104659-25-107829 |
| 2025-11-06 | 16:15 ET | [8-K](/filings/0001104659-25-107740.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-107740 |
| 2025-08-06 | 16:28 ET | [10-Q](/filings/0001558370-25-010541.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010541 |
| 2025-08-06 | 16:06 ET | [8-K](/filings/0001104659-25-074712.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-074712 |
| 2025-06-25 | 16:15 ET | [8-K](/filings/0001104659-25-062576.md) | 5.07 Shareholder vote results | 0001104659-25-062576 |
| 2025-05-08 | 16:30 ET | [10-Q](/filings/0001558370-25-006989.md) | Quarterly report, period 2025-03-31 | 0001558370-25-006989 |
| 2025-05-08 | 16:21 ET | [8-K](/filings/0001104659-25-046149.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-046149 |
| 2025-04-24 | 16:30 ET | [DEF 14A](/filings/0001104659-25-038675.md) | Proxy statement, period 2025-06-23 | 0001104659-25-038675 |
| 2025-02-27 | 16:43 ET | [10-K](/filings/0001558370-25-001826.md) | Annual report, period 2024-12-31 | 0001558370-25-001826 |
| 2025-02-27 | 16:38 ET | [8-K](/filings/0001104659-25-018275.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-018275 |
| 2024-12-17 | 16:16 ET | [8-K](/filings/0001104659-24-129378.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-129378 |
| 2024-11-13 | 16:16 ET | [10-Q](/filings/0001558370-24-015531.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015531 |
| 2024-11-13 | 16:10 ET | [8-K](/filings/0001104659-24-117691.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-117691 |
| 2024-09-17 | 16:15 ET | [8-K](/filings/0001104659-24-100668.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-100668 |
| 2024-08-27 | 16:16 ET | [8-K](/filings/0001104659-24-093434.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-093434 |
| 2024-08-08 | 16:23 ET | [10-Q](/filings/0001558370-24-011616.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011616 |
| 2024-08-08 | 16:14 ET | [8-K](/filings/0001104659-24-087275.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-087275 |
| 2024-06-27 | 17:00 ET | [8-K](/filings/0001104659-24-075724.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001104659-24-075724 |
| 2024-06-03 | 16:59 ET | [8-K](/filings/0001104659-24-067836.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-067836 |
| 2024-06-03 | 16:02 ET | [S-1](/filings/0001104659-24-067768.md) | Registration statement | 0001104659-24-067768 |
| 2024-06-03 | 08:00 ET | [8-K](/filings/0001104659-24-067483.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-067483 |
| 2024-05-09 | 16:56 ET | [10-Q](/filings/0001558370-24-007642.md) | Quarterly report, period 2024-03-31 | 0001558370-24-007642 |
| 2024-05-09 | 16:10 ET | [8-K](/filings/0001104659-24-059329.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-059329 |
| 2024-04-25 | 16:14 ET | [DEF 14A](/filings/0001104659-24-051972.md) | Proxy statement, period 2024-06-25 | 0001104659-24-051972 |
| 2024-03-08 | 09:19 ET | [10-K](/filings/0001558370-24-002791.md) | Annual report, period 2023-12-31 | 0001558370-24-002791 |
| 2024-03-08 | 08:43 ET | [8-K](/filings/0001104659-24-032121.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-032121 |
| 2023-12-18 | 08:28 ET | [8-K](/filings/0001104659-23-126639.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-126639 |
| 2023-11-17 | 17:25 ET | [S-1](/filings/0001104659-23-119620.md) | Registration statement | 0001104659-23-119620 |
| 2023-11-17 | 16:55 ET | [10-Q](/filings/0001558370-23-019203.md) | Quarterly report, period 2023-09-30 | 0001558370-23-019203 |
| 2023-11-17 | 16:51 ET | [10-Q/A](/filings/0001558370-23-019202.md) | Quarterly report, amended, period 2023-06-30 | 0001558370-23-019202 |
| 2023-11-16 | 17:13 ET | [10-Q/A](/filings/0001558370-23-019165.md) | Quarterly report, amended, period 2023-06-30 | 0001558370-23-019165 |
| 2023-11-14 | 17:17 ET | [8-K](/filings/0001104659-23-118241.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-118241 |
| 2023-09-29 | 07:50 ET | [8-K](/filings/0001104659-23-105038.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-105038 |
| 2023-09-29 | 07:38 ET | [8-K](/filings/0001104659-23-105027.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-105027 |
| 2023-08-10 | 16:41 ET | [10-Q](/filings/0001558370-23-014524.md) | Quarterly report, period 2023-06-30 | 0001558370-23-014524 |
| 2023-08-10 | 16:19 ET | [8-K](/filings/0001104659-23-089815.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-089815 |

Page 1 of 2. [Older](/companies/gpcr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.